Document:

Exhibit 10.14

 

THIS INSTRUMENT AND ANY SECURITIES
ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED
EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION
THEREFROM.

 

SPLITTY TRAVEL LTD.

 

SAFE

(Simple Agreement for Future
Equity)

 

THIS CERTIFIES THAT in exchange
for the payment by _________________ (the “Investor”) of US$__________________ (the “Purchase Amount”)
on or about Closing Date (as defined below), Splitty Travel Ltd., a company incorporated under the laws of the State of Israel, company
no. 51-570301-5 (the “Company”), shall issue to the Investor the right to certain shares of the Company’s share
capital, subject to the terms set forth below.

 

This SAFE is one in a series
of Simple Agreements for Future Equity bearing identical terms (the “SAFE Agreements”) executed or to be executed between
the Company and certain investors, prior to, on or following the date hereof and until the Closing Date (“Investors”).

 

The “Valuation Cap”
is $21,000,000.

 

The “Discount Rate”
is 90%.

 

See Section 2 for certain
additional defined terms.

 

1. Events

 

 (a) Equity Financing.
If there is an Equity Financing before the expiration or termination of this instrument, the Company will automatically, in conjunction
with the consummation of the Equity Financing, issue to the Investor a number of Safe Preferred Shares equal to the Purchase Amount divided
by the Conversion Price, provided however, that, except if the Equity Financing is a Down Round, if the Conversion Price
obtained pursuant to the terms hereof is lower than the Minimum PPS, then the number of Safe Preferred Shares that the Company will issue
to the Investor in conjunction with the consummation of the Equity Financing shall be equal to the Purchase Amount divided by the Minimum
PPS. Notwithstanding the foregoing, if the Equity Financing is made at a Company valuation which is lower than the Minimum Valuation (a
“Down Round”), the number of Safe Preferred Shares that the Company will issue to the Investor in conjunction with
the consummation of the Equity Financing shall be equal to the price per share determined in such Equity Financing (without a discount
thereon).

 

 In connection with the
issuance of Safe Preferred Shares by the Company to the Investor pursuant to this Section 1(a), the Investor will execute and deliver
to the Company all transaction documents related to the Equity Financing, applicable to the Investor; provided, that such documents
are substantiality the same documents to be entered into with the purchasers of Standard Preferred Shares, with appropriate variations
for the Safe Preferred Shares if applicable.

 

 (b) Liquidity
Event. If there is a Liquidity Event before the expiration or termination of this instrument, the Investor will, at its option,
either (i) receive a cash payment equal to the Purchase Amount (subject to the following paragraph) or (ii) receive from the Company a
number of Ordinary Shares equal to the Purchase Amount divided by the Liquidity Price, if the Investor fails to select the cash option,
within 7 days from notice by the Company of the final terms of such Liquidity Event.

 

     

     

    

 

In connection with Section
(b)(i), the Purchase Amount will be due and payable by the Company to the Investor solely upon the consummation of the Liquidity Event
and shall be payable in preference to any prior to any Distribution to any Company equityholders or any equity entitlements owed by the
Company. If there are not enough funds to pay the Investor and holders of other Safes (collectively, the “Cash-Out Investors”)
in full, then all of the Company’s funds available for Distribution will be distributed with equal priority and pro rata
among the Cash-Out Investors in proportion to their Purchase Amounts, and the Cash-Out Investors will receive the number of Ordinary Shares
equal to the remaining unpaid Purchase Amount divided by the Liquidity Price.

 

(c) Dissolution Event.
If there is a Dissolution Event before this instrument expires or terminates, the Company will pay an amount equal to the Purchase Amount,
due and payable to the Investor solely upon the occurrence of a Dissolution Event; provided however, that Investor shall be entitled
to convert this Safe into the most senior class of Company shares existing at such time in the Company’s Articles of Association,
at a conversion price equal to the Safe Price (the “Pre-Dissolution Conversion”). Unless the Investor opts for the
Pre-Dissolution Conversion, the Purchase Amount will be paid prior and in preference to any Distribution of any of the assets of the
Company to holders of outstanding Share Capital by reason of their ownership thereof. If immediately prior to the consummation of the
Dissolution Event, the assets of the Company legally available for distribution to the Investor and all holders of all other Safes (the
“Dissolving Investors”), as determined in good faith by the Company’s board of directors, are insufficient to
permit the payment to the Dissolving Investors of their respective Purchase Amounts, then, subject to applicable law, the entire assets
of the Company legally available for distribution will be distributed with equal priority and pro rata among the Dissolving Investors
in proportion to the Purchase Amounts they would otherwise be entitled to receive pursuant to this Section 1(c).

 

(d) Distribution.
If there is a Distribution before this instrument expires or terminates, the Investor shall be afforded a right to convert the Purchase
Amount, prior to the time of such Distribution (and notice of such Distribution shall be provided to the Investor by the Company, at least
7 days prior to the effective date of such Distribution) into the most senior class of shares of the Company outstanding at such time,
at a price per share equal to the Safe Price.

 

(e) Termination.
This instrument will expire and terminate (without relieving the Company of any obligations arising from a prior breach of or non-compliance
with this instrument) upon either (i) the issuance of shares to the Investor pursuant to Section 1(a) or Section 1(b)(ii) or Section 1(d);
or (ii) the payment, or setting aside for payment, of amounts due the Investor pursuant to Section 1(b)(i) or Section 1(c).

 

2. Definitions

 

 “Share Capital”
means the share capital of the Company, including, without limitation, “Ordinary Shares” and the “Preferred
Shares.”

 

 “Change of Control”
means (i) a transaction or series of related transactions as a result of which more than 50% of the Share Capital are transferred
to any third party (other than the issuance of shares by the Company solely in connection with a round of financing), (ii) any reorganization,
merger or consolidation of the Company, other than a transaction or series of related transactions in which the holders of the voting
securities of the Company outstanding immediately prior to such transaction or series of related transactions retain, immediately after
such transaction or series of related transactions, at least a majority of the total voting power represented by the outstanding voting
securities of the Company or such other surviving or resulting entity (iii) a sale, lease or other disposition with the same economic
effect of a sale of all or substantially all of the assets of the Company, or (iv) the grant of an exclusive and substantially worldwide
license to all or substantially all of the intellectual property of the Company with the same economic effect of a sale.

 

 “Closing Date”
a date agreed between the Company and the majority of the Investors, occurring no later than 10 business days after the Company enters
into SAFE Agreements for an aggregate investment thereunder of at least US$1,000,000.

 

“Company Capitalization”
means the sum, as of immediately prior to the Equity Financing, of: (1) all Company shares (on an as-converted basis)
issued and outstanding, assuming exercise or conversion of all outstanding vested and unvested options, warrants and other convertible
securities, but excluding (A) this instrument, (B) all other SAFE Agreements, and (C) other Safes and convertible notes; and
(2) all shares reserved and available for future grant under any equity incentive or similar plan of the Company, and/or any equity
incentive or similar plan to be created or increased in connection with the Equity Financing.

 

    2

     

    

 

“Conversion Price”
means either: (1) the Safe Price, or (2) the Discount Price, whichever calculation results in a greater number of Safe Preferred Shares. 

 

“Discount Price”
means the price per share of the Preferred Shares sold in the Equity Financing multiplied by the Discount Rate.

 

“Distribution”
means the transfer to holders of Share Capital by reason of their ownership thereof of cash or other property without consideration whether
by way of dividend or otherwise, other than dividends on Ordinary Shares payable in Ordinary Shares, or the purchase or redemption of
Ordinary Shares by the Company or its subsidiaries for cash or property other than: (i) repurchases of Ordinary Shares held by employees,
officers, directors or consultants of the Company or its subsidiaries pursuant to an agreement providing, as applicable, a right of first
refusal or a right to repurchase shares upon termination of such service provider’s employment or services; or (ii) repurchases
of Share Capital in connection with the settlement of disputes with any shareholder of the Company.

 

 “Dissolution
Event” means (i) a voluntary termination of operations, (ii) a general assignment for the benefit of the Company’s creditors
or (iii) any other liquidation, dissolution or winding up of the Company (excluding a Liquidity Event), whether voluntary
or involuntary.

 

“Equity Financing”
means a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which the Company raises
at least $3,000,000 (excluding any convertible securities such as warrants, SAFEs or convertible loan agreements) at a fixed Company valuation
in return for the issuance of Standard Preferred Shares.

 

“Initial Public
Offering” means the closing of the Company’s first firm commitment underwritten initial public offering of Ordinary Shares
pursuant to a registration statement filed under the Securities Act or any other securities act in any other jurisdiction.

 

“Liquidity Capitalization”
means the number, as of immediately prior to the Liquidity Event, of Company shares (on an as-converted basis) outstanding, assuming
exercise or conversion of all outstanding vested and unvested options, warrants and other convertible securities, but excluding:
(i) shares reserved and available for future grant under any equity incentive or similar plan; (ii) this instrument; (iii) other SAFE
Agreements; and (iv) other Safes and convertible notes.

 

 “Liquidity Event”
means a Change of Control or an Initial Public Offering.

 

“Liquidity Price”
means the price per share equal to the Valuation Cap divided by the Liquidity Capitalization.

 

“Minimum PPS”
means the price per share equal to the Minimum Valuation divided by the Company Capitalization.

 

 “Minimum
Valuation” means US$19,500,000.

 

“Safe”
means an instrument containing a future right to shares of Share Capital, similar in form and content to this instrument, purchased by
investors for the purpose of funding the Company’s business operations.

 

    3

     

    

 

“Safe Preferred
Shares” means the shares of a series of Preferred Shares issued to the Investor in an Equity Financing, having the identical
rights, privileges, preferences and restrictions as the Standard Preferred Shares, other than with respect to: (i) the per share liquidation
preference and the conversion price for purposes of price-based anti-dilution protection, which will equal the Conversion Price; and (ii)
the basis for any dividend rights, which will be based on the Conversion Price.

 

“Safe Price”
means the price per share equal to the Valuation Cap divided by the Company Capitalization.

 

“Standard Preferred
Shares” means the Preferred Shares issued to the investors investing new money in the Company in the framework of the Equity
Financing.

 

“Subsequent Convertible
Securities” means convertible securities that the Company may issue after the issuance of this instrument with the principal
purpose of raising capital, including but not limited to, other Safes, convertible debt instruments and other convertible securities.
Subsequent Convertible Securities excludes: (i) options issued pursuant to any equity incentive or similar plan of the Company; (ii) convertible
securities issued or issuable to (A) banks, equipment lessors, financial institutions or other persons engaged in the business of making
loans pursuant to a debt financing or commercial leasing or (B) suppliers or third party service providers in connection with the provision
of goods or services pursuant to transactions; and (iii) convertible securities issued or issuable in connection with sponsored research,
collaboration, technology license, development, OEM, marketing or other similar agreements or strategic partnerships.

 

3. “MFN”
Amendment Provision. If the Company issues any Subsequent Convertible Securities prior to termination of this Safe, the
Company will, subject to customary confidentiality undertakings, promptly provide the Investor with written notice thereof, together with
a copy of such Subsequent Convertible Securities and, upon written request of the Investor, any additional information related to such
Subsequent Convertible Securities as may be reasonably requested by the Investor. In the event the Investor determines that the terms
of the Subsequent Convertible Securities are preferable to the terms of this instrument, the Investor will notify the Company in writing.
Promptly after receipt of such written notice from the Investor, the Company agrees to amend and restate this instrument to be identical
to the instrument(s) evidencing the Subsequent Convertible Securities.

 

4. Company
Representations and Covenants

 

(a) The Company is
a corporation duly organized, validly existing and in good standing under the laws of the state of its incorporation, and has the power
and authority to own, lease and operate its properties and carry on its business as now conducted.

 

(b) The execution,
delivery and performance by the Company of this instrument is within the corporate power of the Company and, other than with respect to
the actions to be taken when equity is to be issued to the Investor, has been duly authorized by all necessary actions on the part of
the Company. This instrument constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance
with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement
of creditors’ rights generally and general principles of equity.

 

(c) The performance
and consummation of the transactions contemplated by this instrument do not and will not: (i) violate any material judgment, statute,
rule or regulation applicable to the Company; (ii) result in the acceleration of any material indenture or contract to which the
Company is a party or by which it is bound; or (iii) result in the creation or imposition of any lien upon any property, asset or
revenue of the Company or the suspension, forfeiture, or nonrenewal of any material permit, license or authorization applicable to the
Company, its business or operations.

 

    4

     

    

 

(d) No consents or
approvals are required in connection with the performance of this instrument, other than: (i) the Company’s corporate approvals;
(ii) any qualifications or filings under applicable securities laws; and (iii) necessary corporate approvals for the authorization of
Share Capital issuable pursuant to Section 1.

 

5. Investor
Representations

 

(a) The Investor has
full legal capacity, power and authority to execute and deliver this instrument and to perform its obligations hereunder. This instrument
constitutes valid and binding obligation of the Investor, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency
or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles
of equity.

 

(b) The Investor is an
accredited investor, qualified investor, sophisticated investor or similar definition under Investor’s applicable jurisdiction,
which exempts the issuance of shares to the Investor from prospectus, registration statement or other regulatory requirements.

 

(c) The Investor has
been advised that this instrument and the underlying securities have not been registered under any securities laws and, therefore, may
not be resold unless they are duly registered under applicable law, or unless an exemption from such registration requirements is available.
The Investor is purchasing this instrument and the securities to be acquired by the Investor hereunder for its own account for investment,
not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and the Investor has no
present intention of selling, granting any participation in, or otherwise distributing the same. The Investor has such knowledge and experience
in financial and business matters that the Investor is capable of evaluating the merits and risks of such investment, is able to incur
a complete loss of such investment without impairing the Investor’s financial condition and is able to bear the economic risk of
such investment for an indefinite period of time.

 

6. Miscellaneous

 

(a) Any
provision of this instrument may be amended, waived or modified only upon the written consent of the Company and those Investors who have
invested over 50% of the aggregate amounts invested under this Agreement and all other SAFE Agreements, at such time. 

 

(b) Any notice required
or permitted by this instrument will be deemed sufficient when delivered personally or by overnight courier or sent by email to the relevant
address listed on the signature page, or 48 hours after being deposited in the mail as certified or registered mail with postage prepaid,
addressed to the party to be notified at such party’s address listed on the signature page, as subsequently modified by written
notice.

 

(c) The Investor is
not entitled, as a holder of this instrument, to vote or receive dividends or be deemed the holder of Share Capital for any purpose, nor
will anything contained herein be construed to confer on the Investor, as such, any of the rights of a shareholder of the Company or any
right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or to give or withhold
consent to any corporate action or to receive notice of meetings, or to receive subscription rights or otherwise until shares have been
issued upon the terms described herein.

 

(d) Neither this instrument
nor the rights contained herein may be assigned, by operation of law or otherwise, by either party without the prior written consent of
the other; provided, that the Company may assign this instrument in whole, without the consent of the Investor, in connection with
a reincorporation to change the Company’s domicile.

 

(e) In the event any one
or more of the provisions of this instrument is for any reason held to be invalid, illegal or unenforceable, in whole or in part or in
any respect, or in the event that any one or more of the provisions of this instrument operate or would prospectively operate to invalidate
this instrument, then and in any such event, such provision(s) only will be deemed null and void and will not affect any other provision
of this instrument and the remaining provisions of this instrument will remain operative and in full force and effect and will not be
affected, prejudiced, or disturbed thereby.

 

 (f) All rights and
obligations hereunder will be governed by the laws of the State of Israel, without regard to the conflicts of law provisions of such jurisdiction.

 

 (g) Acknowledging that
the Company is subject to the provisions of the Israeli Research & Development Law - 1984 and of the rules and regulations promulgated
thereunder, including the rules and regulations of the Israeli Innovation Authority (the “IIA”), by virtue of receiving
a grant from the IIA, the Investor agrees that upon conversion of the Purchase Amount in accordance with the terms herein, the Investor
shall execute a standard undertaking towards the IIA, but only if such is required by applicable law.

 

(Signature page follows)

 

    5

     

    

 

IN WITNESS WHEREOF, the undersigned have caused this
instrument to be duly executed and delivered.

 

	SPLITTY TRAVEL LTD.	 
	 	 
	By:	 	 
	Name:	 	 
	Title:	 	 
	Address:  	 	 
	 	 
	 	 	 
	Email:	 	 
	 	 	 
	[name]:	 	 
	 	 
	 	 	 
	Address:	 	 
	 	 
	 	 
	Email:	 	 

 

 

6Exhibit 10.15

 

THIS INSTRUMENT AND ANY SECURITIES
ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED
EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.

 

Holisto
Ltd.

 

SAFE 

 

(Simple Agreement for Future
Equity) 

 

Signed on ___________, 2021 (the
“Execution Date”)

 

THIS CERTIFIES THAT in exchange
for the payment by ______________ (the “Investor”) of ______________ (the “Purchase Amount”) within
[Ÿ] days from the Effective Date, Holisto Ltd., a company incorporated under the laws
of the State of Israel (the “Company”), shall issue to the Investor the right to certain shares of the Company’s
Share Capital, all as specified and subject to the terms set forth below.

 

The “Discount Rate”
shall be 80%.

 

The “Valuation Cap”
is US$600,000,000.

 

See Section 3 for certain
additional defined terms.

 

1.
EFFECTIVENESS

 

This instrument shall enter
into force and effect upon the signing of the Definitive SPAC Agreements by the Company, the Merger Sub (as defined therein) and the SPAC,
as applicable (the “Effective Date”), upon which time, the Investor shall be required to transfer the Purchase Amount
to the Company and, upon receipt of the Purchase Amount by the Company, the Investor shall have the right to be issued with certain shares
of the Company’s Share Capital, all as specified and subject to the terms set forth below. In the event the Definitive SPAC Agreements
shall not have been signed by the Company the Merger Sub and the SPAC, as applicable, prior to the lapse of 6 months from the Execution
Date, this instrument shall become null and void, ab initio.

 

2.
Events

 

(a) SPAC
Transaction. If there is a SPAC Transaction at any time before the expiration or termination of this instrument, immediately
prior and subject to the closing of such SPAC Transaction (but, for the avoidance of doubt, immediately following any capital
restructuring of the Company effected in connection therewith), this instrument will automatically convert into, and the Company
will automatically issue to the Investor, a number of Ordinary Shares equal to the Purchase Amount divided by the SPAC Conversion
Price (rounded to the nearest whole share).

 

In connection with the
issuance of Ordinary Shares by the Company to the Investor pursuant to this Section 2(a), the Investor will execute and deliver to the
Company all applicable transaction documents related to the SPAC Transaction; provided, that such documents are the same documents
which are being entered into by shareholders of the Company (if and to the extent applicable), in connection with the SPAC Transaction,
including, without limitation and as applicable, documents related to lock-up, stop transfer and the like.

 

(b) Equity
Financing. If this instrument has not otherwise terminated or expired upon the lapse of 12 months from such time when the
Investor has actually invested the Purchase Amount in the Company (such time on which such 12 months lapse - the “Final
Date”), then, at any time thereafter, if there is an Equity Financing at any time before the expiration or termination of
this instrument, the Company will automatically issue to the Investor a number of Safe Shares equal to the Purchase Amount divided
by the Equity Financing Conversion Price.

 

In connection with the issuance
of Safe Shares by the Company to the Investor pursuant to this Section 2(b), the Investor will execute and deliver to the Company all
applicable transaction documents related to the Equity Financing; provided, that such documents are the same documents to be entered
into with the purchasers of Standard Shares, with appropriate variations for the Safe Shares if applicable.

 

     

     

    

 

(c) Liquidity
Event. If this instrument has not terminated or expired upon the Final Date, then, at any time thereafter, if there is a Liquidity
Event at any time before the expiration or termination of this instrument, the Investor will be entitled to either (i) receive a cash
payment equal to two times (2X) the Purchase Amount, or (ii) receive from the Company a number of Ordinary Shares equal to the Purchase
Amount divided by the Liquidity Conversion Price. The Investor shall notify the Company in writing of its decision, at least 7 days prior
to the closing of the Liquidity Event, and absent such notification, shall be deemed to have elect option (ii) above

 

(d) Dissolution Event.
If there is a Dissolution Event before this instrument expires or terminates, the Company will pay an amount equal to the Purchase Amount,
due and payable to the Investor immediately prior to, or concurrent with, the consummation of the Dissolution Event. The Purchase Amount
will be paid prior and in preference to any Distribution of any of the assets of the Company to holders of outstanding shares by reason
of their ownership thereof. If immediately prior to the consummation of the Dissolution Event, the assets of the Company legally available
for distribution to the Investor and all holders of all other Safes (the “Dissolving Investors”), as determined in
good faith by the Company’s board of directors, are insufficient to permit the payment to the Dissolving Investors of their respective
Purchase Amounts, then the entire assets of the Company legally available for distribution will be distributed with equal priority and
pro rata among the Dissolving Investors in proportion to the Purchase Amounts they would otherwise be entitled to receive pursuant
to this Section 2(d).

 

(e) Termination.
This instrument will expire and terminate (without relieving the Company of any obligations arising from a prior breach of or
non-compliance with this instrument) upon either: (i) the issuance of shares to the Investor pursuant to Section 2(a), Section 2(b)
or Section 2(c); or (ii) the payment, or setting aside for payment, of amounts due the Investor pursuant to Section 2(c) or Section
2(d). Notwithstanding the foregoing, and for the avoidance of doubt, all of the representations and warranties of the Company
contained in Section 4 below shall automatically terminate and expire upon the termination or expiration of this instrument.

 

3.
Definitions

 

“Change of Control”
means: (i) a transaction or series of related transactions in which any person or entity, becomes the beneficial owner, directly or indirectly,
of more than 50% of the outstanding voting shares of the Company having the right to vote for the election of members of the Company’s
board of directors, (ii) any reorganization, merger or consolidation of the Company, other than a transaction or series of related transactions
in which the holders of the voting shares of the Company outstanding immediately prior to such transaction or series of related transactions
retain, immediately after such transaction or series of related transactions, at least a majority of the total voting power represented
by the outstanding voting shares of the Company or such other surviving or resulting entity, or (iii) a sale, lease or other disposition
of all or substantially all of the assets of the Company, including a worldwide exclusive license to all or substantially all of the Company’s
intellectual property.

 

“Definitive SPAC
Agreements” means (i) a definitive agreement among the Company, the Merger Sub and a publicly listed “special purpose
acquisition company” (“SPAC”) (and/or one or more of its subsidiaries) for effecting a SPAC Transaction, and
(ii) subscription agreements pursuant to which certain subscribers subscribe for convertible notes of the Company, in the aggregate amount
of not less than US$75,000,000.

 

“Dissolution
Event” means: (i) a voluntary termination of operations, (ii) a general assignment for the benefit of the Company’s creditors
or (iii) any other liquidation, dissolution or winding up of the Company (excluding a Liquidity Event), whether voluntary or involuntary.

 

“Distribution”
means the transfer to holders of Share Capital by reason of their ownership thereof of cash or other property without consideration whether
by way of dividend or otherwise, other than dividends on Ordinary Shares payable in Ordinary Shares, or the purchase or redemption of
Share Capital by the Company or its subsidiaries for cash or property other than: (i) repurchases of shares held by employees, officers,
directors or consultants of the Company or its subsidiaries pursuant to an agreement providing, as applicable, a right of first refusal
or a right to repurchase shares upon termination of such service provider’s employment or services; or (ii) repurchases of Share
Capital in connection with the settlement of disputes with any shareholder.

 

    2

     

    

 

“Equity Financing”
means a bona fide transaction or series of related transactions with the principal purpose of raising capital, pursuant to which the Company
issues and sells shares at a fixed pre-money valuation.

 

“Equity Financing
Capitalization” means the sum, as of immediately prior to the Equity Financing, of: (1) the Share Capital (on an as-converted
basis) issued and outstanding, assuming exercise or conversion of all outstanding vested and unvested options, warrants and other convertible
securities, but excluding (A) this instrument, (B) all other Safes, and (C) convertible loans or convertible notes; and (2) all
Ordinary Shares of the Company reserved and available for future grant under any equity incentive or similar plan of the Company, but
excluding increase of Company’s option pool made in the framework of the Equity Financing, if applicable.

 

“Equity Financing
Conversion Price” means either (i) the Equity Financing Safe Price, or (ii) the Equity Financing Discount Price, whichever calculation
results in a greater number of Safe Shares.

 

“Equity Financing
Discount Price” means the price per share of the Standard Shares sold in the Equity Financing multiplied by the Discount Rate.

 

“Equity Financing
Safe Price” means the price per share equal to the Valuation Cap divided by the Equity Financing Capitalization.

 

“Initial Public
Offering” means the closing of the Company’s first firm commitment underwritten initial public offering of the Ordinary
Shares pursuant to a registration statement filed under the Securities Act, or under any other applicable securities laws.

 

“Liquidity Capitalization”
means the sum, as of immediately prior to the Liquidity Event, of: (1) the Share Capital (on an as-converted basis) issued and
outstanding, assuming exercise or conversion of all outstanding vested and unvested options, warrants and other convertible securities,
but excluding (A) this instrument, (B) all other Safes, and (C) convertible loans or convertible notes; and (2) all Ordinary Shares
of the Company actually allocated or promised under any equity incentive or similar plan of the Company.

 

“Liquidity Conversion
Price” means either (i) the Liquidity Discount Price, or (ii) the Liquidity Safe Price, whichever calculation results in a greater
number of Ordinary Shares.

 

“Liquidity Discount
Price” means the price per each share of the Company, as determined by reference to the aggregate purchase price paid or payable
in connection with such Liquidity Event (including without limitation any portion of such purchase price placed in escrow or payable
upon satisfaction of contingencies or the like), multiplied by the Discount Rate.

 

“Liquidity Event”
means a Change of Control or an Initial Public Offering, but, in each case, specifically excluding the SPAC Transaction.

 

 “Liquidity Safe
Price” means the price per share equal to the Valuation Cap divided by the Liquidity Capitalization.

 

 “Ordinary Shares”
means Company’s Ordinary Shares, NIS 0.01 par value each.

 

“Safe”
means an instrument containing a future right to shares of the Company’s Share Capital, similar in form and content to this instrument,
purchased by investors for the purpose of funding the Company’s business operations.

 

“Safe Shares”
means the shares issued to the Investor in an Equity Financing, having the identical rights, privileges, preferences and restrictions
as the Standard Shares, other than with respect to: (i) the per share liquidation preference and the (initial) conversion price for purposes
of price-based anti-dilution protection, which will equal the Equity Financing Conversion Price; and (ii) the basis for any dividend rights,
which will be based on the Equity Financing Conversion Price.

 

    3

     

    

 

“Share Capital”
means the share capital of the Company.

 

“SPAC Conversion
Price” means US$8.00.

 

“SPAC Transaction”
means the closing of a transaction resulting in the initial registration of the Company’s Ordinary Shares (or initial or continued
registration of the class of securities exchanged for Company securities in such transaction) under the Securities Exchange Act of 1934,
as amended (or equivalent securities law of another jurisdiction).

 

“Standard Shares”
means the shares issued to the investors investing in the Company in connection with the initial closing of an Equity Financing.

 

4.
Company Representations

 

(a) The Company is
a corporation duly organized, validly existing and in good standing under the laws of the state of its incorporation, and has the power
and authority to own, lease and operate its properties and carry on its business as now conducted.

 

(b) The execution,
delivery and performance by the Company of this instrument is within the corporate power of the Company and, other than with respect to
the actions to be taken when equity is to be issued to the Investor, has been duly authorized by all necessary actions on the part of
the Company. This instrument constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance
with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement
of creditors’ rights generally and general principles of equity. To the knowledge of the Company, it is not in violation of: (i)
its amended articles of association as currently in effect; (ii) any material statute, rule or regulation applicable to the Company; or
(iii) any material contract to which the Company is a party or by which it is bound, where, in each case, such violation or default, individually,
or together with all such violations or defaults, could reasonably be expected to have a material adverse effect on the Company.

 

(c) The performance
and consummation of the transactions contemplated by this instrument do not and will not: (i) violate any material judgment, statute,
rule or regulation applicable to the Company; (ii) result in the acceleration of any material contract to which the Company is a
party or by which it is bound; or (iii) result in the creation or imposition of any lien upon any property, asset or revenue of the
Company or the suspension, forfeiture, or nonrenewal of any material permit, license or authorization applicable to the Company, its business
or operations.

 

(d) No consents or
approvals are required in connection with the performance of this instrument, other than: (i) the Company’s corporate approvals
and waiver of participation rights by the Company’s applicable shareholders; and (ii) necessary corporate approvals for the authorization
of shares of the Company issuable pursuant to Section 2 hereof.

 

(e) To its knowledge,
the Company owns or possesses (or can obtain on commercially reasonable terms) sufficient legal rights to all patents, trademarks, service
marks, trade names, copyrights, trade secrets, licenses, information, processes and other intellectual property rights necessary for its
business as now conducted and as currently proposed to be conducted, without any conflict with, or infringement of, the rights of others.

 

5.
Investor Representations

 

(a) The Investor has
full legal capacity, power and authority to execute and deliver this instrument and to perform its obligations hereunder. This instrument
constitutes valid and binding obligation of the Investor, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency
or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles
of equity.

 

(b) The Investor is
an accredited investor, qualified investor, sophisticated investor or similar definition under Investor’s applicable jurisdiction,
which exempts the issuance of shares to the Investor from prospectus, registration statement or other regulatory requirements. The Investor
has been advised that this instrument and the underlying securities have not been registered under the Securities Act, or any state securities
laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state securities laws or unless
an exemption from such registration requirements is available. The Investor is purchasing this instrument and the securities to be acquired
by the Investor hereunder for its own account for investment, not as a nominee or agent, and not with a view to, or for resale in connection
with, the distribution thereof, and the Investor has no present intention of selling, granting any participation in, or otherwise distributing
the same. The Investor has such knowledge and experience in financial and business matters that the Investor is capable of evaluating
the merits and risks of such investment, is able to incur a complete loss of such investment without impairing the Investor’s financial
condition and is able to bear the economic risk of such investment for an indefinite period of time.

 

    4

     

    

 

6.
Miscellaneous

 

(a) Any
provision of this instrument may be amended, waived or modified only by a written instrument signed by the Company and the majority in
interest out of all of the persons/entites (including the Investor) (collectively, the “Safe Investors”) who invest (or
have invested) in the Company under instruments substantially similar to this instrument (not including for the removal
of doubt, instruments which are outstanding prior to November 25, 2021) (such majority out of the Safe Investors, the “Majority
Investors”), whose determination shall bind all of the Safe Investors (including the Investor), provided however
that any amendment, waiver or modification which adversely and disproportionally amends the rights of a specific investor compared to
the rights of other investors, shall require such specific investor’s written consent.

 

(b) Any notice required
or permitted by this instrument will be deemed sufficient when delivered personally or by overnight courier or sent by email to the
relevant address listed on the signature page, or 48 hours after being deposited in the mail as certified or registered mail with
postage prepaid, addressed to the party to be notified at such party’s address listed on the signature page, as subsequently
modified by written notice.

 

(c) The Investor is
not entitled, as a holder of this instrument, to vote or receive dividends or be deemed the holder of Share Capital for any purpose, nor
will anything contained herein be construed to confer on the Investor, as such, any of the rights of a shareholder of the Company or any
right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or to give or withhold
consent to any corporate action or to receive notice of meetings, or to receive subscription rights or otherwise until shares have been
issued upon the terms described herein.

 

(d) Neither this
instrument nor the rights contained herein may be assigned, by operation of law or otherwise, by either party without the prior
written consent of the other; provided, however, that this instrument and/or the rights contained herein may be assigned
without the Company’s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is
under common control with the Investor; and provided, further, that the Company may assign this instrument in whole, without
the consent of the Investor, in connection with a reincorporation to change the Company’s domicile or with the prior written
consent of the Majority Investors.

 

(e) In the event any one
or more of the provisions of this instrument is for any reason held to be invalid, illegal or unenforceable, in whole or in part or in
any respect, or in the event that any one or more of the provisions of this instrument operate or would prospectively operate to invalidate
this instrument, then and in any such event, such provision(s) only will be deemed null and void and will not affect any other provision
of this instrument and the remaining provisions of this instrument will remain operative and in full force and effect and will not be
affected, prejudiced, or disturbed thereby.

 

(f) All rights and
obligations hereunder will be governed by the laws of the State of Israel, without regard to its conflicts of law provisions. Any dispute
arising under or in relation to this Agreement shall be resolved exclusively in the competent court for Tel Aviv-Jaffa district, and each
of the parties hereby irrevocably submits to the exclusive jurisdiction of such court.

 

[Signature
page follows]

 

    5

     

    

 

IN WITNESS WHEREOF, the undersigned have caused this
instrument to be duly executed and delivered.

 

	 	HOLISTO Ltd.
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 
	 	Address:	 
	 	Email:	 
	 	 	 
	 	[investor]
	 	 	 
	 	By:	      
	 	Name:	 
	 	Title:	 
	 	Address:	 
	 	Email:	 

 

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]